Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention

Despite treatment with statins, patients with elevated low-density lipoprotein cholesterol (LDL-C) and triglycerides remain at increased risk for adverse cardiovascular events. Consequently, novel pharmaceutical drugs have been developed to control and modify the composition of blood lipids to ultim...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaeli, Daniel Tobias, Michaeli, Julia Caroline, Albers, Sebastian, Boch, Tobias, Michaeli, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462544/
https://www.ncbi.nlm.nih.gov/pubmed/37486464
http://dx.doi.org/10.1007/s40256-023-00594-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462544/
https://www.ncbi.nlm.nih.gov/pubmed/37486464
http://dx.doi.org/10.1007/s40256-023-00594-5

Ejemplares similares